Totect Articles
Apricus Biosciences closes Topotarget USA acquisition
30 December 2011
TopoTarget's Totect achieves 2007 gains
3 March 2008
R&D expenses increase TopoTarget's loss 26%
19 November 2007
TopoTarget launches Totect in USA
22 October 2007
TopoTarget's Totect cleared by FDA
17 September 2007
TopoTarget's 2nd-qtr loss widens to $17.1M
3 September 2007
TopoTarget gets US FDA
4 June 2007
TopoTarget's loss grows 282%, on R&D costs
26 March 2007
John Parsons to head new US subsidiary of TopoTarget A/S
20 November 2006
TopoTarget set to launch Savene in EU
25 September 2006
TopoTarget's Savene cleared by EC
7 August 2006
FDA priority review for TopoTarget's Totect
17 April 2006
Showing 1-12 of 12 articles
- 1
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Italy's pharma market slump set to continue, warns GlobalData
